Hepatitis B prevention. Part 1: A review of ACIP's newest guidelines.
D000062:Accidents, Occupational; D003362:Cost-Benefit Analysis; D005260:Female; D006509:Hepatitis B / Q000191:economics / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D017325:Hepatitis B Vaccines; D006801:Humans; D007115:Immunization Schedule; D007116:Immunization, Passive; D008297:Male; D009784:Occupational Diseases / Q000191:economics / Q000517:prevention & control*; D010564:Personnel, Hospital; D011247:Pregnancy; D014761:Viral Hepatitis Vaccines
D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines